Detected ·
Sidewinder Therapeutics
——
Sidewinder Therapeutics raised an oversubscribed $137M Series B led by Frazier Life Sciences and Novartis Venture Fund to advance precision bispecific ADCs into clinical development for difficult-to-treat solid tumors.
- Website
- —
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-04-09 00:04:16 UTC
- Signal ID
- bd819c21-82f2-49e9-8cda-18ee7d5dd83a
As the API returns it
{
"id": "bd819c21-82f2-49e9-8cda-18ee7d5dd83a",
"created_at": "2026-04-09T00:04:16.339136Z",
"company_name": "Sidewinder Therapeutics",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/sidewinder-therapeutics-inc",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Sidewinder Therapeutics raised an oversubscribed $137M Series B led by Frazier Life Sciences and Novartis Venture Fund to advance precision bispecific ADCs into clinical development for difficult-to-treat solid tumors.*"
}